A novel orally active Group 2 metabotropic glutamate receptor agonist: LY354740

NeuroReport

Volumn 8, Issue 6, 1997, Pages 1463-1466

  Bond, Ann ^a   Monn, James A ^a   Lodge, David ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Bioavailability; Blood brain barrier; Metabotropic glutamate receptors

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; EGLUMETAD; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; LY 314582; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG POTENTIATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD NERVE CELL; STEREOISOMERISM; STEREOSPECIFICITY;

EID: 0030904243     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199704140-00027     Document Type: Article

References (12)

1. Nakanishi S. Science 258, 597-603 (1992).
2. Pin J-P and Duvoisin R. Neuropharmacology 34, 1-26 (1995).
3. Baker SR, Goldsworthy J, Harden RC et al. Biorg Med Chem Lett 5, 223-228 (1995).
4. Schoepp DD, Salhoff CR, Wright RA et al. Neuropharmacology, in press (1996).
5. Monn JA, Valli MJ, Johnson BG et al. J Med Chem 39, 2990-3000 (1996).
6. Monn JA, Valli MJ, Massey SM et al. J Med Chem, in press (1997).
7. Schoepp DD, Johnson BG, Wright RA et al. Neuropharmacology, in press (1997).
8. Bond A and Lodge D. Neuropharmcology 34, 1015-1023 (1995).
9. Lodge D and Bond A. J Physiol 493, 50P (1996).
10. Schoepp DD and Conn PJ. Trends Pharmacol Sci 14, 13-20 (1993).
11. Knopfel T and Gasparini F. Drug Discovery Today 1, 103-108 (1996).
12. Nicoletti F, Bruno V, Copani A et al. Trends Neurosci 19, 267-271 (1996).